Pharmaceutical

XKDCT-080 by Guangdong Xiankangda Biotechnology for Colorectal Cancer: Likelihood of Approval

XKDCT-080is under clinical development by Guangdong Xiankangda Biotechnology and currently in Phase II for Colorectal Cancer.

Jul 1, 2023 - 20:00
XKDCT-080is under clinical development by Guangdong Xiankangda Biotechnology and currently in Phase II for Colorectal Cancer.
Read the original article

Tags:

Previous Article

Cold agglutinin disease by NovelMed Therapeutics for Acquired (Autoimmune) Hemol...

Next Article

ABBV-444 by AbbVie for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Genetically altered pig heart transplanted into a human for the second time

Genetically altered pig heart transplanted into a human...

Sep 22, 2023

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid ...

Nov 7, 2024

What does generative AI mean for health care? We asked the experts

What does generative AI mean for health care? We asked ...

May 23, 2023